Peak Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559K Hold
6,178
0.08% 110
2026
Q1
$495K Hold
6,178
0.09% 97
2025
Q4
$527K Hold
6,178
0.09% 95
2025
Q3
$480K Sell
6,178
-165
-3% -$12.9K 0.08% 98
2025
Q2
$496K Hold
6,343
0.09% 98
2025
Q1
$460K Hold
6,343
0.09% 97
2024
Q4
$470K Hold
6,343
0.09% 100
2024
Q3
$419K Hold
6,343
0.08% 108
2024
Q2
$586K Hold
6,343
0.11% 90
2024
Q1
$606K Hold
6,343
0.12% 91
2023
Q4
$484K Hold
6,343
0.11% 96
2023
Q3
$439K Hold
6,343
0.11% 95
2023
Q2
$598K Hold
6,343
0.14% 87
2023
Q1
$525K Hold
6,343
0.13% 91
2022
Q4
$473K Hold
6,343
0.12% 89
2022
Q3
$524K Sell
6,343
-40
-0.6% -$3.85K 0.15% 83
2022
Q2
$607K Hold
6,383
0.17% 85
2022
Q1
$751K Sell
6,383
-20
-0.3% -$2.24K 0.17% 80
2021
Q4
$830K Sell
6,403
-222
-3% -$25.9K 0.19% 77
2021
Q3
$750K Hold
6,625
0.18% 79
2021
Q2
$686K Hold
6,625
0.17% 82
2021
Q1
$554K Hold
6,625
0.13% 95
2020
Q4
$604K Buy
6,625
+270
+4% +$22.4K 0.16% 82
2020
Q3
$507K Hold
6,355
0.15% 81
2020
Q2
$439K Buy
6,355
+391
+7% +$27.8K 0.14% 80
2020
Q1
$375K Buy
+5,964
New +$430K 0.14% 76

Other funds holding EW

Peak Asset Management's EW Position: Q2 2026 in Review

Peak Asset Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 6,178 shares worth $559K. The position accounts for 0.08% of the portfolio, ranked #110.

Peak Asset Management first reported a position in EW in Q1 2020 and has held it in 26 quarters since. The position peaked at $830K in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Peak Asset Management held 6,178 shares of Edwards Lifesciences worth $559K as of Q2 2026.
  • Peak Asset Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.08% of Peak Asset Management's portfolio in Q2 2026, its #110 holding.
  • Peak Asset Management first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 26 quarters since.
  • Peak Asset Management's Edwards Lifesciences position peaked at $830K in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Peak Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.